Press release
Platinum Based Cancer Drug Market: Size, Share, Growth Trends, and Leading Players Forecast by 2024-2031 - Pfizer, Inc., Accord Healthcare, Sanofi.
Platinum Based Cancer Drug Market
Get a Free Sample PDF - https://datamintelligence.com/download-sample/platinum-based-cancer-drug-market
What is the projected growth rate (CAGR) of the Global Platinum Based Cancer Drug market from 2024 to 2031, and what is the market value expected to change by 2031?
The global platinum-based cancer drug market reached USD 1.4 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 1.8 billion by 2031. The global platinum-based cancer drug market is expected to exhibit a CAGR of 3.2% during the forecast period (2024-2031).
What is Platinum Based Cancer Drug Market?
Platinum-based cancer drugs, such as cisplatin, carboplatin, and oxaliplatin, are essential in oncology, used primarily for their effectiveness against various cancers, including testicular, ovarian, lung, and colorectal cancers. These drugs work by forming DNA cross-links, which interfere with DNA replication and transcription, ultimately leading to cancer cell death. Despite their efficacy, platinum-based therapies are associated with side effects like nausea, nephrotoxicity, and ototoxicity, which can limit their use. Research continues to explore combination therapies and new formulations to enhance their efficacy and reduce side effects.
Who are the major players in the Platinum Based Cancer Drug market?
The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world. The prominent players in Platinum Based Cancer Drug market research report are:
Pfizer, Inc., Accord Healthcare, Sanofi, Sun Pharmaceutical Industries Ltd., MorphoSys AG, Dr. Reddy's Laboratories Ltd., Eisai Co., Ltd., Regeneron Pharmaceuticals Inc., Novartis AG and Merck & Co.
Key Development
On June 4, 2023, during the Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Amgen presented new findings from the CodeBreaK clinical trial program, which is the largest global development initiative focused on patients with KRAS G12C-mutated cancers. The results demonstrate the efficacy of LUMAKRAS/LUMYKRAS (sotorasib) in treating advanced colorectal cancer (mCRC) and non-small cell lung cancer (NSCLC). Notably, the study highlights the safety and effectiveness of combining sotorasib with platinum-based chemotherapy as a first-line treatment for patients with advanced NSCLC harboring the KRAS G12C mutation, marking a significant advancement in therapeutic options for this patient population.
Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=platinum-based-cancer-drug-market
Regions Covered:
The global Platinum Based Cancer Drug Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Market Segments
By Drug Type: Cisplatin, Oxaliplatin, Carboplatin, Others.
By Application: Colorectal Cancer, Lung Cancer, Breast Cancer, Others.
By End User: Hospitals, Specialty Clinics, Other.
The Platinum Based Cancer Drug industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.
Key Features
➥ Leverage epidemiology insights to tailor precision diagnostics and address region-specific needs.
➥ Meet critical unmet needs in complex conditions with advanced, precise Platinum Based Cancer Drug industry solutions for better diagnostics and outcomes.
➥ Stay ahead with real-time pipeline analysis, revealing the latest Platinum Based Cancer Drug innovations and market trends.
➥ Optimize your offerings with competitive pricing analysis, balancing cost-effectiveness and cutting-edge tech.
➥ Protect your innovation with expert patent analysis, ensuring strategic positioning in the Platinum Based Cancer Drug market.
➥ Gain an edge with comprehensive competitive intelligence, guiding informed decisions in Platinum Based Cancer Drug
➥ Maximize market presence with brand share analysis, strengthening your position in the Platinum Based Cancer Drug landscape.
➥ Accurately predict market demand for Platinum Based Cancer Drug with precise drug sales forecasting insights.
Get Customization in the report as per your requierments: https://datamintelligence.com/customize/platinum-based-cancer-drug-market
FAQs
What does the Platinum Based Cancer Drug market report provide?
The report provides a detailed analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Active, Innovators, Start-ups, and Cutting Edge) that are anticipated to influence its future growth trajectory.
What is the scope of the market report?
The market report covers regional analysis and provides detailed insights into the Platinum Based Cancer Drug market including market size, segmentation, and key players.
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Platinum Based Cancer Drug Market: Size, Share, Growth Trends, and Leading Players Forecast by 2024-2031 - Pfizer, Inc., Accord Healthcare, Sanofi. here
News-ID: 3713343 • Views: …
More Releases from DataM Intelligence 4market Research LLP
United States Plant Breeding and CRISPR Plant Market Outlook 2024-2031: Innovati …
Plant Breeding and CRISPR Plant Market is forecasted to reach at a CAGR of 10.87% during the forecast period (2024-2031).
This market focuses on improving crop yield, quality, and resistance through modern breeding techniques and CRISPR-based genome editing. Plant breeding innovations support food security by developing climate-resilient and pest-resistant varieties. CRISPR technology enables precise genetic modifications, reducing time compared to conventional breeding. Market growth is driven by increasing global food demand…
Recent Developments in Neuromorphic Computing: Intel, IBM, Qualcomm, Fujitsu, So …
The Global Neuromorphic Computing Market reached USD 48.3 million in 2022 and is projected to witness lucrative growth by reaching up to USD 6,801.9 million by 2030. The global neuromorphic computing market is expected to exhibit a CAGR of 91.5% during the forecast period (2024-2031).
The neuromorphic computing market revolves around hardware and systems modeled on the human brain's neural architecture, enabling advanced processing and learning capabilities. These systems aim to…
Strategic Collaborations in Electric Aircraft Charging Infrastructure: Partnersh …
Global Electric Aircraft Charging Interfaces Market reached USD 0.54 billion in 2023 and is expected to reach USD 2.1 billion by 2031 growing with a CAGR of 20.7% during the forecast period 2024-2031.
This market involves charging systems and interfaces that enable electric and hybrid-electric aircraft to recharge efficiently and safely. With the aviation industry pushing toward sustainable solutions, these interfaces are critical for commercial, private, and urban air mobility vehicles.…
Anti-Obesity Drugs Market Recent Developments 2025: Key Updates from the U.S., E …
Global Anti-Obesity Drugs Market reached US$ 2.5 billion in 2022 and is expected to reach US$ 43.7 billion by 2030 growing with a CAGR of 45.5% during the forecast period 2024-2031.
The anti-obesity drugs market includes pharmaceuticals designed to promote weight loss by suppressing appetite, reducing fat absorption, or enhancing energy expenditure. Rising global obesity rates, linked to sedentary lifestyles and unhealthy diets, are driving market demand. Approved drugs include orlistat,…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
